Education and Training
BA - Middlebury College, Middlebury, VT
MS in Clinical Research Organization and Management - Drexel University College of Medicine, Philadelphia, PA
Titles and Academic Titles
Departments and Services
Chung, D.C., Bertelsen, M., Lorenz, B., Pennesi, M.E., Leroy, B.P., Hamel, C.P., Pierce, E., Sallum, J., Larsen, M., Stieger, K., Preising, M., Weleber, R., Yang, P., Place, E., Liu, E., Schaefer, G., DiStefano-Pappas, J., Elci, O.U., McCague, S., Wellman, J.A., High K.A., Reape K.Z. (2019) The Natural History of Inherited Retinal Dystrophy Due to Biallelic Mutations in the RPE65 Gene. Am J Ophthalmol. 199, 58-70.
Maguire, A.M., Russell, S., Wellman, J.A., Chung, D.C., Yu, Z.F., Tillman, A., Wittes, J., Pappas, J., Elci, O., Marshall, K.A., McCague, S.,… Bennett, J. (2019) Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials. Ophthalmology, 126(9), 1273-1285.
Chung, D.C., McCague, S., Yu, Z-F., Thill, S., DiStefano-Pappas, J., Bennett, J., … High, K.A. (2017) Novel mobility test to assess functional vision in patients with inherited retinal dystrophies. Clinical & Experimental Ophthalmology, 2017 August 31.
Russell, S., Bennett, J., Wellman, J.A., Chung, D.C., Yu, Z-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., … Maguire, A.M. (2017). Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: A randomised, controlled, open-label, phase 3 trial. The Lancet, 390(10097), 849-860.
Bennett, J., Wellman, J., Marshall, K.A., McCague, S., Ashtari, M., DiStefano-Pappas, J., … Maguire, A.M. (2016). Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: A follow-on phase 1 trial. The Lancet, 388(10045), 661-672.
McCague, S., Wellman, J., Yu, F., Thill, S., DiStefano-Pappas, J., Bennett, J., … Chung, D.C. Mobility testing validation study – Using a novel, standardized mobility test to evaluate functional vision in patients with inherited retinal degeneration. Poster presented at: Association for Research in Vision and Ophthalmology Annual Meeting; 2015 May 3-7; Denver, CO.
Bennett, J., Ashtari, M., Wellman, J., Marshall, K.A., Cyckowski, L.L., Chung, D.C., McCague, S., … Maguire, A.M. (2012). AAV2 gene therapy readministration in three adults with congenital blindness. Science Translational Medicine, 4(120), 120ra15.
Awards and Honors
2018, Academic Excellence Award, Drexel University College of Medicine
Patient Experience Ratings
About the Patient Experience Rating System
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.